AJMC January 19, 2025
Skylar Jeremias

Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist, discussed how artificial intelligence (AI) is revolutionizing lung cancer care by analyzing imaging data to detect malignancies and interstitial lung disease, while stressing the importance of regulation to ensure its safe and ethical use.

Artificial intelligence is playing a growing role in advancing lung cancer care, particularly in diagnostics and treatment. Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist at the Oncology Institute of Hope and Innovation, highlighted artificial intelligence’s potential in analyzing imaging data, such as identifying irregularities in x-rays or computer tomography (CT) scans that may indicate malignancies, as well as detecting patterns of interstitial lung disease caused by medication or radiation.

Additionally, artificial...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Provider, Survey / Study, Technology, Trends
MIT’s Dean of Computing: 4 Inconvenient Truths About GenAI
Live from AONL 2025: 3 Major Concerns for CNOs
Nvidia open sources Run:ai Scheduler to foster community collaboration
The Role – and Benefits – of AI in RTLS
Clearing The Crux: Five Paths To Achieve Health Policy Change In 2025

Share This Article